Fesoterodine
Fesoterodine is an antimuscarinic (anticholinergic) agent. It is a prodrug that is rapidly and extensively hydrolyzed by non-specific esterases to its active metabolite, which acts as a competitive antagonist of muscarinic receptors to help relax the detrusor muscle in the bladder.
Dosage by Body Weight
The recommended starting dose for adults is 4 mg taken orally once daily. Based on individual response and tolerability, the dose may be increased to 8 mg once daily. Tablets must be swallowed whole with liquid and should not be chewed, divided, or crushed.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and effectiveness have not been established in pediatric patients in this weight range.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness have not been established in pediatric patients in this weight range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness have not been established in pediatric patients in this weight range.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness have not been established in pediatric patients in this weight range.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness have not been established. Pediatric dosing (for neurogenic detrusor overactivity) is typically reserved for children 6 years and older weighing more than 25 kg.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and effectiveness have not been established in pediatric patients in this weight range. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness have not been established in pediatric patients in this weight range. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness have not been established in pediatric patients in this weight range. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness have not been established in pediatric patients in this weight range. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness have not been established. Pediatric dosing (for neurogenic detrusor overactivity) is typically reserved for children 6 years and older weighing more than 25 kg. |
Formulation
Purpose
Treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and frequency.
Generic Name
Fesoterodine fumarateBranded Drug Names
Fesoterodine is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:
Scheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.